LivaNova LIVN
NASDAQ LIVN
$78.96 -1.74 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

LivaNova (LIVN) Total Non-Current Liabilities (2015 - 2026)

LivaNova's (LIVN) quarterly Total Non-Current Liabilities came in at $1.2 billion in Q2 2026, down 12.66% year-over-year from $1.3 billion in Q2 2025, and down 3.3% quarter-over-quarter from $1.2 billion in Q1 2026.

Analysis

LivaNova (LIVN) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends

LivaNova has disclosed Total Non-Current Liabilities across 12 years of filings, most recently posting $1.2 billion for Q2 2026.

  • In Q2 2026, Total Non-Current Liabilities fell 12.66% year-over-year to $1.2 billion; the TTM figure through Jun 2026 stood at $1.2 billion (down 12.66% YoY), while the FY2025 annual figure was $1.3 billion, up 19.25% from the prior year.
  • Total Non-Current Liabilities came in at $1.2 billion for Q2 2026 at LivaNova, down from $1.2 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $1.4 billion in Q1 2025 to a low of $920.2 million in Q2 2022.
  • Average Total Non-Current Liabilities over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2024.
  • Year-over-year, Total Non-Current Liabilities retreated 26.91% in 2022 and increased 27.02% in 2025.
  • Over 5 years, Total Non-Current Liabilities stood at $995.6 million in 2022, then climbed by 7.58% to $1.1 billion in 2023, then gained by 2.88% to $1.1 billion in 2024, then advanced by 19.25% to $1.3 billion in 2025, then declined by 11.52% to $1.2 billion in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $1.2 billion in Q2 2026, $1.2 billion in Q1 2026, and $1.3 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 1.92 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 40.46 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 21.28 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 17.56 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 2.57 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 6.34 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 3.68 Bn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 3.44 Bn
10 LivaNova 4.34 Bn 3.82 Bn 273.67 Mn 1.16 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.16 Bn
Mar 31, 2026 1.20 Bn
Dec 31, 2025 1.31 Bn
Sep 30, 2025 1.34 Bn
Jun 30, 2025 1.33 Bn
Mar 31, 2025 1.44 Bn
Dec 31, 2024 1.10 Bn
Sep 30, 2024 1.13 Bn
Jun 30, 2024 1.11 Bn
Mar 31, 2024 1.13 Bn
Dec 31, 2023 1.07 Bn
Sep 30, 2023 1.01 Bn
Jun 30, 2023 1.01 Bn
Mar 31, 2023 977.43 Mn
Dec 31, 2022 995.59 Mn
Sep 30, 2022 982.77 Mn
Jun 30, 2022 920.15 Mn
Mar 31, 2022 954.37 Mn
Dec 31, 2021 819.48 Mn
Sep 30, 2021 786.83 Mn